Refractory pyoderma gangrenosum associated with rheumatoid arthritis successfully treated with upadacitinib. Comments on: "JAK inhibitors: a novel, safe, and efficacious therapy for pyoderma gangrenosum".
| Autor: | Dos Santos MR; Hospital de Doenças Tropicais Dr Anuar Auad, Goiânia, Goiás, Brazil., Ianhez M; Hospital de Doenças Tropicais Dr Anuar Auad, Goiânia, Goiás, Brazil., Ribeiro BN; Centro Médico Alameda, Goiânia, Goiás, Brazil., de Queiroz BB; Hospital de Doenças Tropicais Dr Anuar Auad, Goiânia, Goiás, Brazil., Miot HA; Universidade Estadual Paulista Júlio de Mesquita Filho - Campus de Botucatu, Botucatu, São Paulo, Brazil. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | International journal of dermatology [Int J Dermatol] 2023 Nov; Vol. 62 (11), pp. e595-e598. Date of Electronic Publication: 2023 Jul 10. |
| DOI: | 10.1111/ijd.16791 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Plný text